TRAJ18 and neoplasm: Indeed, the tumour growth in the DC-αGalCer treated Trαj18-/- mice was similar to that in the vehicle-treated WT and Trαj18-/- mouse groups, demonstrating the absolute requirement for activated iNKT cells in tumour rejection (78).